Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 0.8 mg/ml - oral liquid - excipient ingredients: benzoic acid; maltitol solution; menthol; purified water; sucralose; flavour - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions, such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 1.6 mg/ml - oral liquid - excipient ingredients: menthol; purified water; benzoic acid; sucralose; maltitol solution; flavour - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions, such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 0.8 mg/ml - oral liquid - excipient ingredients: maltitol solution; hyetellose; benzoic acid; sucralose; purified water; flavour - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions, such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim pty limited, vetmedica division - oxytetracycline; lignocaine; bromhexine hydrochloride - oral solution/suspension - oxytetracycline antibiotic active 0.0 undefined; lignocaine caine active 20.0 mg/ml; bromhexine hydrochloride guanidine active 0.0 undefined - respiratory system - calf | pig - piglet | pigs | beef calf | boar | bovine | calf - poddy | calf - preweaning | calf - sucker | dairy calf | gilt | - bronchitis | mycoplasma hyopneumoniae | pneumonia | pneumonia - viral | rhinitis | bacterial pneumonia | reduction of lung lesions | respiratory disease | swine enzootic pneumonia

Malta - English - Medicines Authority

sanofi malta limited - bromhexine hydrochloride - oral solution - bromhexine hydrochloride 4 mg/5ml - cough and cold preparations

Malta - English - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - bromhexine hydrochloride - oral solution - bromhexine hydrochloride 4 milligram(s)/5 millilitre - cough and cold preparations

Malta - English - Medicines Authority

opella healthcare france sas t/a sanofi 157 avenue charles de gaulle, 92200 neuilly-sur-seine , france - bromhexine hydrochloride - oral solution - bromhexine hydrochloride 4 mg/5ml - cough and cold preparations